As of 3:59pm ET
| -0.03 / -0.24%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 10.75, with a high estimate of 14.00 and a low estimate of 5.50. The median estimate represents a -12.68% decrease from the last price of 12.31.
The current consensus among 7 polled investment analysts is to Hold stock in Mesoblast Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.